Chromophobe Renal Cell Carcinoma
Last Posted: Mar 09, 2023
- The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
Ball Mark W, et al. European urology focus 2017 0 (6) 584-589
- Chromophobe renal cell carcinoma: New genetic and metabolic insights.
Zhang Long, et al. Urologic oncology 2020 0 (8) 678-681
- Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
Ohashi Riuko, et al. Cancers 2020 0 (2)
- Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Liu Qingqing, et al. The American journal of pathology 2018 0 (4) 846-852
- Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.
Rebouissou Sandra, et al. Human molecular genetics 2005 0 (5) 603-14
- Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation.
Wentland Andrew L et al. Abdominal radiology (New York) 2022
- Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing.
Mollica Veronica, et al. Pathology, research and practice 2021 2 153350
- Automated Differentiation of Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma on Computed Tomography Using Deep Learning.
Baghdadi Amir et al. BJU international 2020 Jan
- [Correlation studies of distinct mutational signatures with common cancer pathological subtyping].
Shi Yue, et al. Yi chuan = Hereditas 2018 11 (11) 1033-1038
- Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.
Ito Timothy, et al. The Journal of urology 2015 11
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.